tiprankstipranks
Trending News
More News >
Kao Corp (JP:4452)
:4452

Kao (4452) AI Stock Analysis

Compare
1 Followers

Top Page

JP

Kao

(OTC:4452)

Rating:80Outperform
Price Target:
¥7,614.00
▲(15.68%Upside)
Kao's strong financial health and positive earnings call contribute significantly to its stock score. While technical analysis indicates strong momentum, valuation reflects a fair market value. Challenges such as overseas sales decline and potential tariff impacts are notable risks.
Positive Factors
Efficiency and Restructuring
Kao has implemented structural reforms aimed at enhancing efficiency and revamping its organization, which are expected to offset potential raw material cost increases.
Sales Growth
Kao appears to have firmly turned around and is on the path to recovery, with a projected increase in net sales across all regions.
Strategic Initiatives
The 'Global Sharp Top Strategy' aims to achieve significant growth by shifting from quantity to quality in product development and expanding the global rollout of high-value-added products.
Negative Factors
Currency Volatility
Potential volatility of JPY may cap near term re-rating and limit upside from currency translation effects.
Environmental Impact
Key downside risks include the prolonged impact of treated water disposal from the Fukushima nuclear power plant and consumption weakness.
Market Risks
Key downside risks include consumption weakness, an increase in input costs, and unsuccessful management's restructuring efforts.

Kao (4452) vs. iShares MSCI Japan ETF (EWJ)

Kao Business Overview & Revenue Model

Company DescriptionKao Corporation develops and sells cosmetic, skin/hair care, human health care, fabric and home care, and chemical products. It operates through five segments: Hygiene and Living Care Business, Health and Beauty Care Business, Life Care Business, Cosmetics Business, and Chemical Business. The Hygiene and Living Care Business segment offers laundry detergents; fabric treatments; kitchen, paper, and house cleaning products; sanitary napkins; and baby diapers. The Health and Beauty Care Business segments provides skin and hair care products, professional hair care products, bath additives, and oral care and thermo products. The Life Care Business segments offers health drinks, as well as hygiene products for commercial use. The Cosmetics Business segment provides counseling and self-selection cosmetic products. The Chemical Business segment offers oleo chemicals; fat and oil derivatives; surfactants; fragrances; water-reducing admixtures; casting sand binders; plastics additives; process chemicals; toners and toner binders; inkjet ink colorants and ink; fine polishing agents and cleaners; and materials and process chemicals. The company was formerly known as Kao Soap Co., Ltd. and changed its name to Kao Corporation in 1982. Kao Corporation was founded in 1887 and is headquartered in Tokyo, Japan.
How the Company Makes MoneyKao Corporation generates revenue through the sale of its diverse range of consumer goods and chemical products. The company's revenue streams are primarily divided into four segments: Beauty Care, Health Care, Fabric and Home Care, and Chemicals. The Beauty Care segment includes skincare, haircare, and cosmetics, which are sold under various brand names through retail channels. The Health Care segment encompasses sanitary products and personal health items. The Fabric and Home Care segment offers household cleaning products, such as laundry detergents and cleaning agents. Additionally, Kao's Chemicals segment provides chemical products that cater to industries such as electronics, automotive, and construction. The company's earnings are bolstered by strategic partnerships, research and development investments, and a strong marketing presence to maintain its competitive edge in the global market.

Kao Earnings Call Summary

Earnings Call Date:May 08, 2025
(Q1-2025)
|
% Change Since: 8.94%|
Next Earnings Date:Jul 30, 2025
Earnings Call Sentiment Neutral
The earnings call reflects a balanced outlook with significant growth in sales and operating income, driven by strong performance in the Japanese market and cosmetics turnaround. However, challenges remain with overseas sales declines, potential tariff impacts, and high raw material prices.
Q1-2025 Updates
Positive Updates
Sales and Operating Income Growth
Net sales increased by 6.6% to ¥389.9 billion. Operating income rose to ¥31.2 billion, with the operating margin improving to 8%.
Cosmetics Business Turnaround
Operating income for the cosmetics segment improved by ¥4.2 billion. Strategic investments in six focus brands and inventory optimization in China contributed to this growth.
Significant Net Income Increase
Net income attributable to owners of the parent was ¥22.8 billion, up 38.7% year-on-year.
Improved ROIC and Gross Margin
ROIC improved by 1.5 points year-on-year. Gross margin improved by 0.5 percentage points to 38%.
Japanese Market Performance
In Japan, cosmetics grew 10.8%, fabric and home care grew 9.3%, and health beauty care grew 7.1%, contributing significantly to overall sales growth.
Successful UV Care Business Expansion
UV care sales grew 9% year-on-year. Significant growth in the U.S. e-commerce channel by 150% year-on-year.
Negative Updates
Overseas Sales Decline
Overseas sales fell by 1.9%, affected by strategic shifts in Asia and intensifying competition in the Americas and Europe.
Impact of U.S. Tariff Policy
New risks from U.S. tariffs may impact operating income by up to ¥2 billion. Measures are being taken to minimize this impact.
Challenges with Raw Material Prices
Continued high prices for fats and oils and palm kernel oil, with an anticipated impact of ¥10 billion for the year.
Company Guidance
During the call, the guidance for fiscal 2025 highlighted a focus on building a solid foundation for global growth, with specific metrics indicating strong performance in the first quarter. Net sales increased by 6.6% to ¥389.9 billion, while excluding currency impacts, the growth was 6%. The operating income reached ¥31.2 billion, reflecting a significant operating margin improvement to 8%. Net income attributable to owners increased by 38.7% to ¥22.8 billion, with earnings per share rising by 38.9% to ¥49.19. The cosmetics segment made progress toward reaching an operating income target of ¥7 billion, and the UV care business saw a 9% sales increase. The GC business reported a 4% net sales growth, driven by a 7.6% increase in the Japanese market, while overseas sales fell slightly by 1.9%. The operating margin in the sanitary products segment improved by 4.4 points to 5.8%, and the overall gross margin rose by 0.5 percentage points to 38%. The company also addressed risks from U.S. tariffs, estimating a potential maximum impact on operating income of ¥2 billion, which they plan to mitigate through various measures.

Kao Financial Statement Overview

Summary
Kao shows strong financial performance with robust revenue growth and improving profitability. The balance sheet is stable, though there are concerns about leverage. Cash flow generation is solid but shows potential volatility.
Income Statement
85
Very Positive
Kao demonstrates strong revenue growth, with a TTM (Trailing-Twelve-Months) increase, signaling a robust growth trajectory. Gross profit margins remain healthy, reflecting effective cost management. The net profit margin is improving, indicating enhanced profitability. However, slight fluctuations in EBIT and EBITDA margins suggest some operational challenges.
Balance Sheet
80
Positive
The balance sheet is strong with a solid equity position, as shown by a stable debt-to-equity ratio. Return on equity has improved, indicating efficient use of shareholder funds. The equity ratio is healthy, suggesting a stable financial structure. However, the presence of significant debt, while manageable, points to potential leverage risks.
Cash Flow
78
Positive
Cash flow performance is solid, with positive free cash flow growth. The operating cash flow to net income ratio demonstrates strong cash generation relative to net earnings. The free cash flow to net income ratio also supports financial health. However, fluctuations in investing and financing cash flows highlight potential volatility in capital allocation.
Breakdown
TTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income StatementTotal Revenue
1.65T1.63T1.53T1.55T1.42T1.38T
Gross Profit
628.45B638.40B560.43B548.34B573.19B590.69B
EBIT
155.78B146.64B60.03B110.07B143.51B175.56B
EBITDA
250.12B235.07B154.50B205.46B237.32B260.73B
Net Income Common Stockholders
114.15B107.77B43.87B86.04B109.64B126.14B
Balance SheetCash, Cash Equivalents and Short-Term Investments
278.72B368.24B291.66B271.85B342.16B360.43B
Total Assets
1.77T1.87T1.77T1.73T1.70T1.67T
Total Debt
246.14B245.33B261.07B262.89B268.68B274.21B
Net Debt
-32.58B-112.39B-30.59B-5.36B-67.39B-78.97B
Total Liabilities
715.49B768.40B757.70B730.97B720.13B727.42B
Stockholders Equity
1.03T1.07T983.66B972.06B965.14B923.69B
Cash FlowFree Cash Flow
127.92B144.18B136.03B53.70B104.00B144.87B
Operating Cash Flow
188.34B201.59B202.48B130.91B175.52B214.72B
Investing Cash Flow
-46.13B-45.90B-109.30B-74.91B-67.23B-61.94B
Financing Cash Flow
-113.95B-104.58B-79.98B-139.31B-141.57B-87.06B

Kao Technical Analysis

Technical Analysis Sentiment
Neutral
Last Price6582.00
Price Trends
50DMA
6338.58
Positive
100DMA
6373.78
Positive
200DMA
6452.83
Positive
Market Momentum
MACD
84.43
Positive
RSI
51.21
Neutral
STOCH
18.26
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:4452, the sentiment is Neutral. The current price of 6582 is below the 20-day moving average (MA) of 6642.20, above the 50-day MA of 6338.58, and above the 200-day MA of 6452.83, indicating a neutral trend. The MACD of 84.43 indicates Positive momentum. The RSI at 51.21 is Neutral, neither overbought nor oversold. The STOCH value of 18.26 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for JP:4452.

Kao Peers Comparison

Overall Rating
UnderperformOutperform
Sector (65)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
80
Outperform
¥3.11T27.2111.12%2.27%6.57%105.73%
65
Neutral
$8.76B15.224.69%4.58%3.64%-2.90%
$2.27B60.592.08%0.01%
$2.85B19.807.58%1.85%
$2.02B41.874.49%4.29%
$14.27B22.5811.87%1.21%
60
Neutral
¥986.73B496.62
2.43%-1.33%-139.30%
* Consumer Defensive Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
JP:4452
Kao
6,582.00
3.77
0.06%
KOSCF
Kose
39.78
-27.26
-40.66%
LIOPF
Lion
10.15
2.27
28.81%
PORBF
Pola Orbis Holdings
9.14
1.06
13.12%
UNCHF
Unicharm
7.66
-3.57
-31.79%
JP:4911
Shiseido Company,Limited
2,441.50
-2,220.20
-47.63%

Kao Corporate Events

Kao Corporation Reports Strong Q1 2025 Financial Performance
May 8, 2025

Kao Corporation reported a significant increase in its financial performance for the first quarter of 2025, with net sales rising by 6.6% and net income attributable to owners of the parent increasing by 38.7% compared to the same period in 2024. The company maintains a stable financial position with a slight decrease in total assets but an improved equity ratio. The forecast for the fiscal year ending December 31, 2025, anticipates continued growth in net sales and income, reflecting Kao’s strong market positioning and strategic initiatives.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.